Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000373033

Medchemexpress LLC 2-Methyl-1,2,5,6-tetrahydro-3H-pyrrolo[3,2,1-ij]quinazolin-3-imine hydrochloride | C11H14ClN3 | 5 MG
SDP

Catalog No. 5000373033
Encompass_Preferred

JBSNF-000028 hydrochloride is an orally active, small molecule inhibitor of tricyclic nicotinamide N-methyltransferase (NNMT) with IC50 values of 33 nM for human NNMT. It effectively reduces endogenous MNA levels in U2OS osteosarcoma cells with an EC50 of 2.5 μM. This compound has demonstrated significant anti-obesity and anti-diabetic activities in diet-induced obesity models.

  • Inhibits NNMT activity with an EC50 of 2.5 μM in U2OS cells
  • Shows no cytotoxicity against HepG2 cells at 10-100 μM
  • Improves glucose and lipid handling in mice with diet-induced obesity
  • Improves glucose tolerance in NNMT knockout mice with diet-induced obesity
  • Used for studying metabolic diseases such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease

Catalog No. 50-003-73033 Supplier Medchemexpress LLC Supplier No. HY151500B5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

JBSNF-000028 hydrochloride is an orally active, small molecule inhibitor of tricyclic nicotinamide N-methyltransferase (NNMT) with IC50 values of 33 nM for human NNMT. It effectively reduces endogenous MNA levels in U2OS osteosarcoma cells with an EC50 of 2.5 μM. This compound has demonstrated significant anti-obesity and anti-diabetic activities in diet-induced obesity models.

  • Inhibits NNMT activity with an EC50 of 2.5 μM in U2OS cells
  • Shows no cytotoxicity against HepG2 cells at 10-100 μM
  • Improves glucose and lipid handling in mice with diet-induced obesity
  • Improves glucose tolerance in NNMT knockout mice with diet-induced obesity
  • Used for studying metabolic diseases such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.